This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yu Li - Innovator in Polypeptide Molecules
Introduction
Yu Li is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide molecules. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing scientific knowledge.
Latest Patents
Yu Li holds a patent for "FGF21 Variant Polypeptide Molecules and Application Thereof." This patent highlights his research and development efforts in creating novel polypeptide variants that have potential applications in various therapeutic areas. His work in this domain is a testament to his commitment to innovation and scientific progress.
Career Highlights
Throughout his career, Yu Li has worked with Sunshine Lake Pharma Co., Ltd., where he has contributed to various projects aimed at enhancing pharmaceutical development. His experience in this company has allowed him to collaborate with other talented professionals in the field.
Collaborations
Yu Li has had the opportunity to work alongside notable colleagues such as Chao Chen and Xiaofeng Chen. These collaborations have enriched his research and have played a crucial role in the advancement of his projects.
Conclusion
In summary, Yu Li is an accomplished inventor whose work in polypeptide molecules has the potential to impact the biotechnology industry significantly. His patent and collaborations reflect his dedication to innovation and scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile